Related Experiment Video
Updated: Sep 15, 2025

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain
Published on: May 12, 2018
Memory impairment mediated by deoxynivalenol via the BLA-PrL circuit
Liu-Nan Yang1, Tongxia Li2, Yan Liu3
1Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, Wuhan 430030, China; Department of Infectious Diseases, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Disease, Huazhong University of Science and Technology, Hangkong Road 13, Wuhan 430030, China; Department of Nutrition and Food Hygiene and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, Wuhan 430030, China; NHC Specialty Laboratory of Food Safety Risk Assessment and Standard Development, Hangkong Road 13, Wuhan 430030, China.
None:
The prelimbic cortex (PrL), located in the ventral part of the medial prefrontal cortex (mPFC), collaborates with the basolateral amygdala (BLA) to regulate cognitive functions, particularly in learning and memory. However, it remains unclear whether exposure to deoxynivalenol (DON), a common mycotoxin, disrupts these neural circuits and contributes to cognitive impairments. Our study reveals that DON exposure significantly impairs memory and spatial learning abilities in mice. We found increased connectivity between glutamatergic neurons in the BLA and PrL following DON exposure, indicating its role in memory impairments. Whole-cell patch-clamp recordings demonstrated that DON diminishes excitatory synaptic transmission in the PrL and reduces dendritic complexity and spine density. Notably, activation of BLA-PrL glutamatergic projections alleviated memory impairment induced by DON. Furthermore, our research utilized spatial metabolomics analysis to identify potential intervention targets, specifically Sphingomyelin Synthase 2 (SMS2), that could mitigate the adverse effects of DON on cognitive health by modulating sphingomyelin levels. This study enhances our understanding of the neurobiological mechanisms underlying cognitive dysfunction due to DON exposure and provides valuable insights for public health and clinical strategies.
More Related Videos
Related Concept Videos
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Olfactory Receptors: Location and Structure
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Ligand-Gated Ion Channel Receptor: Gating Mechanism

